Related by context. Frequent words. (Click for all words.) 60 Gemin X 59 novel orally administered 59 TLR9 agonist 59 liposomal formulation 58 anticancer compound 58 kinase inhibitor 58 HCV protease inhibitor 57 MEK inhibitor 56 optical biosensors 56 orally bioavailable 56 REG1 56 proteasome inhibitor 56 HCV protease 56 CA4P 56 Panzem R 55 Cetrorelix 55 vascular disrupting agent 55 IMC A# 55 PSN# [002] 55 ligand binding 55 CCX# 55 synthetic peptides 55 phase IIb clinical 55 Carfilzomib 55 deforolimus 55 targeting CD# 54 mediate RNAi 54 polymerase inhibitors 54 sodium Injection 54 immunomodulating 54 anti fibrotic 54 CORT # 54 HGS ETR1 54 multi kinase inhibitor 54 DB# [003] 54 Guanilib 54 antisense drug 54 HDAC inhibitor 54 OncoVEX GM CSF 54 Hsp# inhibitor 54 Aurora kinase 54 xenograft models 54 Factor VIIa 54 MORAb 54 selectively inhibits 54 Chemokine Therapeutics 54 VQD 54 metabotropic glutamate receptor 54 cancer immunotherapies 54 EGF receptor 54 nucleoside 54 INGN 54 ADME Tox 53 MKC# 53 #ME# 53 polymerase inhibitor 53 hepatocyte growth 53 GLPG# 53 small molecule inhibitor 53 VEGF receptors 53 oncology therapeutics 53 Inotek 53 Celator 53 Idera Pharmaceuticals 53 Kinases 53 antiangiogenic 53 RGB # 53 oncolytic virus 53 immunodiagnostics 53 BAL# [001] 53 DAVANAT 53 FGFR 53 Recombinant Human 53 Proxinium TM 53 antibody fragment 53 Microspheres 53 nitric oxide donating 53 SCH # 53 Regado 53 active comparator 53 neuroprotective properties 53 ALN TTR# 53 JAK3 53 novel anticancer 53 chemotherapy induced neutropenia 53 SU# [003] 53 peptide synthesis 53 GRN#L 53 enzyme inhibitor 53 PK PD 53 Pervasis 53 molecular biomarkers 53 Naproxcinod 53 elotuzumab 53 GENFIT 52 refractory chronic lymphocytic 52 MAb 52 tivozanib 52 Phase 2b clinical trials 52 OX1 52 Promedior